SeaCrest Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-103
Closed -$17K – 1310
2022
Q2
$17K Buy
+103
New +$16.3K ﹤0.01% 1549
2019
Q2
– Sell
-150
Closed -$9K – 1559
2019
Q1
$9K Buy
150
+75
+100% +$4.31K ﹤0.01% 1569
2018
Q4
$4K Buy
+75
New +$4.4K ﹤0.01% 1770

Other funds holding RGEN

SeaCrest Wealth Management's RGEN Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of Repligen (RGEN) in Q3 2022, closing a stake of 103 shares — an estimated $17K sold.

SeaCrest Wealth Management first reported a position in RGEN in Q4 2018 and held it in 3 quarters. The position peaked at $17K in Q2 2022. 434 funds tracked by Wall St. Rank hold RGEN as of Q3 2022.

  • SeaCrest Wealth Management reported no remaining Repligen position as of Q3 2022 after selling out during the quarter.
  • SeaCrest Wealth Management sold 103 Repligen shares in Q3 2022, an estimated $17K.
  • SeaCrest Wealth Management first reported a position in Repligen in Q4 2018 and held it in 3 quarters.
  • SeaCrest Wealth Management's Repligen position peaked at $17K in Q2 2022.
  • 434 funds tracked by Wall St. Rank held Repligen as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.